Sun GY, Chen SY, Tang Y, Fang H, et al. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for
patients with high-risk breast cancer (CHN HYPOPMRT): 10-year outcomes from a
randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol 2026;27:1249-1259.
PMID: 42805199
|